Use of a flowable haemostat versus an oxidised regenerated cellulose agent in primary elective cardiac surgery: economic impact from a UK healthcare perspective

Peer Review reports

Original Submission
8 Jun 2017	Submitted	Original manuscript
24 Jun 2017	Reviewed	Reviewer Report - Marios Patronis
4 Oct 2017	Reviewed	Reviewer Report - Eugenio Quaini
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
2 Nov 2017	Editorially accepted
29 Nov 2017	Article published	10.1186/s13019-017-0660-y

Back to article page